Exemestane
Exemestane is an oral medication primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It belongs to a class of drugs known as aromatase inhibitors, which work by reducing the amount of estrogen in the body.

Key Takeaways
- Exemestane is an irreversible steroidal aromatase inactivator used for hormone-receptor-positive breast cancer.
- It works by significantly reducing estrogen production, thereby inhibiting the growth of estrogen-sensitive cancer cells.
- It is primarily prescribed for postmenopausal women, either as adjuvant therapy for early breast cancer or for advanced breast cancer that has progressed after other anti-estrogen treatments.
- Common side effects include hot flashes, joint pain, fatigue, and bone density loss.
- Adherence to prescribed **exemestane dosage and administration** is crucial, and patients should be monitored for potential adverse effects.
What is Exemestane: Mechanism of Action and Therapeutic Uses
Exemestane is an anti-estrogen medication classified as an irreversible steroidal aromatase inactivator. This means it permanently binds to and deactivates the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues, a primary source of estrogen in postmenopausal women. By inhibiting this enzyme, exemestane significantly reduces circulating estrogen levels, which is critical for treating hormone-receptor-positive breast cancers that rely on estrogen for growth.
The primary application for which **what is exemestane used for** is in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It is commonly prescribed as adjuvant therapy for early breast cancer following initial treatment (such as surgery or radiation) to reduce the risk of recurrence. It is also indicated for advanced breast cancer that has progressed after treatment with tamoxifen or other anti-estrogen therapies. According to the World Health Organization (WHO), breast cancer is the most common cancer among women globally, with a significant proportion being hormone-receptor-positive, making therapies like exemestane vital in managing the disease.
To understand **how does exemestane treat breast cancer**, it’s important to recognize that many breast cancers are estrogen-sensitive. Estrogen can stimulate the growth of these cancer cells. Exemestane’s mechanism of action directly targets the production of estrogen, effectively starving these cancer cells of the hormone they need to proliferate. This reduction in estrogen levels helps to slow or stop the growth of existing cancer cells and prevent the formation of new ones, thereby improving patient outcomes and reducing recurrence rates in eligible patients.
Exemestane Dosage, Administration, and Important Safety Information
The typical **exemestane dosage and administration** involves taking one 25 mg tablet orally once daily, preferably after a meal to enhance absorption. The duration of treatment can vary, often extending for several years, depending on the specific clinical situation and patient tolerance, as determined by an oncologist. Consistent adherence to the prescribed regimen is crucial for maximizing therapeutic benefits and managing the disease effectively. Patients should not adjust their dosage or discontinue the medication without consulting their healthcare provider.
Like all medications, exemestane can cause **exemestane side effects and warnings**. Common side effects are generally mild to moderate and may include hot flashes, joint pain, fatigue, headache, insomnia, and nausea. More serious side effects, though less common, can include bone density loss (leading to an increased risk of fractures), elevated cholesterol levels, and liver function abnormalities. Patients should report any persistent or severe side effects to their doctor promptly. Regular monitoring, including bone density scans and lipid profiles, is often recommended during treatment to manage potential risks.
Important warnings associated with exemestane include its contraindication in premenopausal women, pregnant women, and breastfeeding mothers due to potential harm to a developing fetus or infant. Patients with a history of liver or kidney impairment may require careful monitoring or dosage adjustments. It is also important to discuss all current medications, including over-the-counter drugs and herbal supplements, with a healthcare provider to avoid potential drug interactions. This information is supportive only and does not replace professional medical advice or treatment.



















